Publication

Phase II trial of web-based tailored asthma management intervention in adolescents at clinics

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Mei Lu, Henry Ford HospitalTalan Zhang, Henry Ford HospitalDennis R. Ownby, Augusta UniversityEdward Zoratti, Henry Ford HospitalDayna Johnson, Emory UniversityRenee William, Henry Ford HospitalCheryl Miree, Henry Ford HospitalChristine L. M. Joseph, Henry Ford Hospital
Language
  • English
Date
  • 2019-07-01
Publisher
  • Elsevier Science Inc.
Publication Version
Copyright Statement
  • © 2019 Elsevier Inc. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 82
Start Page
  • 46
End Page
  • 52
Grant/Funding Information
  • This work was supported by the National Institutes of Health [grant number R01HL114981–02]
Abstract
  • Clinical trials are critical for medical decision-making; however, conduct is costly and labor intensive. Traditionally, clinical trials are conducted in a controlled environment with a restricted patient population. In addition to the use of electronic initiatives (e-initiatives) such as the use of electronic medical records (EMR) for patient identification, recruitment and data collection, pragmatic clinical trials promote patient enrollment in a “real world” setting with fewer exclusion criteria and less need for research infrastructure. The pragmatic trial also uses comparative adaptive methods and approaches to ensure results provide real-world evidence, i.e., evidence that study execution and data analysis are translatable to practice. Puff City, a web-based, asthma management program for urban adolescents with asthma, has been evaluated in Detroit Public High Schools [1] [2], and results of these school-based randomized trials were promising for potential dissemination beyond schools [1] [2]. To demonstrate pragmatic approaches to conduct of a randomized trial, we extended the Puff City program to a clinical setting and conducted a seamless Phase II/III pragmatic trial of the program in a group of urban, primary care clinics.
Author Notes
  • Correspondence: Mei Lu, Ph.D., Department of Public Health Sciences, Henry Ford Health System, One Ford Place, 3E, Detroit, MI 48202, Telephone: (313) 874-6413, Fax: (313) 874-6730, mlu1@hfhs.org
Keywords
Research Categories
  • Health Sciences, Pharmacology
  • Health Sciences, Public Health
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items